Table 5.
The prognostic factor analysis for the huge group patients.
| Disease-free survival factors | Univariant analysis |
Multivariant analysis |
|---|---|---|
| HR ( 95% CI) | HR ( 95% CI) | |
| Portal vein thrombosis | 7.533 (1.971–28.788) | 7.774 (1.880–31.897) |
| Free margin < 1 mm | 3.403 (1.231–9.411) | 3.423 (1.197–9.790) |
| Advanced T stage (T3+T4) | 2.940 (1.154–7.411) | N.S. |
| Satellite nodules | 3.132 (1.100–8.918) | N.S. |
| Overall survival factors | Univariant analysis |
Multivariant analysis |
|---|---|---|
| HR ( 95% CI) | HR ( 95% CI) | |
| Age over 80 | 4.037 (1.018–16.003) | 12.993 (2.535–66.599) |
| Portal vein thrombosis | 6.785 (1.670–27.576) | 8.953 (1.772–45.223) |
Abbreviation: N.S.: Non-significance.